Rigel Pharmaceuticals (RIGL) Tax Provisions (2021 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Tax Provisions of $3.0 million for Q1 2026, up 4520.0% year-over-year from $65000.0 in Q1 2025, and up 101.22% quarter-over-quarter from -$245.4 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Tax Provisions (2021 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Tax Provisions history runs 4 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- In Q1 2026, Tax Provisions rose 4520.0% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at -$242.3 million (down 25708.77% YoY), while the FY2025 annual figure was -$245.2 million, down 27931.67% from the prior year.
- Tax Provisions for Q1 2026 stood at $3.0 million, up from -$245.4 million in the prior quarter.
- The five-year high for Tax Provisions was $3.0 million in Q1 2026, with the low at -$245.4 million in Q4 2025.
- The 3-year median for Tax Provisions is $217000.0 (2025), against an average of -$40.2 million.
- The sharpest annual moves came in 2025 and 2026: Tax Provisions sank 27949.15% in 2025, then soared 4520.0% in 2026.
- Rigel Pharmaceuticals' Tax Provisions stood at $881000.0 in 2024, then tumbled by 27949.15% to -$245.4 million in 2025, then surged by 101.22% to $3.0 million in 2026.
- Business Quant data shows RIGL's Tax Provisions at $3.0 million in Q1 2026, -$245.4 million in Q4 2025, and -$280000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 6.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.30 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | -245.35 Mn |
| Sep 30, 2025 | -280,000.00 |
| Jun 30, 2025 | 369,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 881,000.00 |
| Dec 31, 2021 | -95,000.00 |
| Sep 30, 2021 | -136,000.00 |
| Jun 30, 2021 | -1.00 Mn |
| Mar 31, 2021 | 1.80 Mn |